NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Shandong Realcan Pharmaceutical Co Ltd Says it gets securities regulator's approval to issue shares in private placement.   Source : reuters.com

news

The U.S. Food and Drug Administration said it would allow the use of an experimental test to screen donated blood for the Zika virus. The test, manufactured by a New Jersey-based unit of Swiss drugmaker Roche Holding AG, may be used for screening donated blood in areas with active mosquito-borne…

news

Drug firm Aurobindo Pharma has received final approval from the USFDA to manufacture and market pantoprazole sodium for injections, used for the treatment of gastroesophageal reflux disease, in the American market. "The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market pantoprazole…

news

Drug major Lupin today said it has received a total of three observations relating to violation of production norms at manufacturing facilities at Mandideep, Madhya Pradesh from the US Food and Drug Administration. However, the company said the observations were "minor in nature" and would not lead to any disruption…

news

Biotech company Aveo Pharmaceuticals Inc will pay $4 million to settle civil charges that it misled investors about U.S. regulators' concerns about its drug to treat kidney cancer, the Securities and Exchange Commission said on Tuesday. Aveo declined to comment on specifics of the settlement. The company neither admitted nor…

news

Keryx Biopharmaceuticals Inc on Tuesday said its drug to treat iron deficiency anemia in chronic kidney disease patients not yet requiring dialysis met the goals of a late stage clinical trial, potentially paving the way for an expanded approval of the treatment. In the 16-week study of 234 patients with…

news

Sun Pharmaceutical Industries Ltd. said it had agreed to buy 14 prescription brands from Novartis AG in a $293 million cash deal that would expand the Indian company’s footprint into Japan. “This acquisition marks Sun Pharma’s foray into the Japanese prescription market and provides us an opportunity to build a…

news

Drug major Dr Reddy's Laboratories (DRL) has entered into a US licensing pact with XenoPort for the development and commercialisation of latter's clinical-stage oral new chemical entity XP23829. Dr Reddy's Laboratories will pay an upfront fee of $50 million (Rs 335 crore) to XenoPort and up to $440 million (Rs…

news

Alder BioPharmaceuticals Inc said on Monday its drug to prevent migraines had met the main goal in a keenly watched mid-stage study. Four doses of the drug, ALD403, were tested against a placebo in patients suffering from chronic migraines. The trial included patients who experienced 15 or more headache days…

news

U.S. launch of Tramadol Hydrochloride extended-release tablets USP, 100 mg, 200 mg and 300 mg. Tramadol Hydrochloride extended-release tablets USP, 100 mg, 200 mg, 300 mg, is generic version of Valeant's Ultram extended-release tablets.   Source : reuters.com